cystathionine gamma-lyase inhibitors (Abnova)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecystathionine gamma-lyase inhibitors (Abnova)
Drug Alias NameCTH inhibitors (Abnova)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystathionine gamma-lyase inhibitors
TargetsCystathionine gamma-lyase
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbnova (Taiwan) Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbnova (Taiwan) Corp
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A